Financials

  • Market Capitalization 62.2197 B
  • Employee 51 K
  • Founded N/A
  • CEO Steven H. Collis
  • Website www.cencora.com
  • Headquarter Delaware, United States
  • FIGI BBG000MDCQC2
  • Industry Technology
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
39.26
市销率
0.19
每股股息
2.2
股息收益率 %
0.7

Cencora Inc

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

新闻